Among the products and services going up for sale are MarketScan, Advantage Suite, Micromedex, CareDiscovery and ActionOI. In a statement, Thomson CEO Tom Glocer said although the business is growing and profitable, the unit lacks integration with the other units and also lacks global scale. As a result of the divestitute, the Intellectual Property and Science businesses will be part of a a single operating unit of the Professional division.